van Doorn R - Search Results

1

Multiple primary melanoma: risk factors -reviewed.

van Doorn R. van Doorn R. Br J Dermatol. 2024 Jan 23;190(2):141-142. doi: 10.1093/bjd/ljad343. Br J Dermatol. 2024. PMID: 37713632 No abstract available.

2

Melanoma diagnosis during periodic surveillance of patients with multiple atypical naevi.

Rauwerdink DJW, Roach REJ, Etty MA, Kukutsch NA, van Doorn R. Rauwerdink DJW, et al. Among authors: van doorn r. Br J Dermatol. 2018 Oct;179(4):997-998. doi: 10.1111/bjd.16708. Epub 2018 Aug 3. Br J Dermatol. 2018. PMID: 29704460 No abstract available.

3

Methylation marks melanoma metastasis.

van Doorn R. van Doorn R. Br J Dermatol. 2018 Aug;179(2):250-251. doi: 10.1111/bjd.16772. Br J Dermatol. 2018. PMID: 30141547 No abstract available.

4

Surveillance for familial melanoma: recommendations from a national centre of expertise.

Halk AB, Potjer TP, Kukutsch NA, Vasen HFA, Hes FJ, van Doorn R. Halk AB, et al. Among authors: van doorn r. Br J Dermatol. 2019 Sep;181(3):594-596. doi: 10.1111/bjd.17767. Epub 2019 May 1. Br J Dermatol. 2019. PMID: 30742720 No abstract available.

5

The value of clinical characteristics for the diagnosis of melanoma in patients presenting at a pigmented lesion clinic.

Roach RE, Plasmeijer EI, van Doorn R, Bergman W, Kukutsch NA. Roach RE, et al. Among authors: van doorn r. Br J Dermatol. 2016 Jun;174(6):1401-3. doi: 10.1111/bjd.14375. Epub 2016 Mar 11. Br J Dermatol. 2016. PMID: 26708210 No abstract available.

6

Complete remission of skin lesions in a patient with subcorneal pustular dermatosis (Sneddon-Wilkinson disease) treated with antimyeloma therapy: association with disappearance of M-protein.

von dem Borne PA, Jonkman MF, van Doorn R. von dem Borne PA, et al. Among authors: van doorn r. Br J Dermatol. 2017 May;176(5):1341-1344. doi: 10.1111/bjd.14954. Epub 2017 Jan 27. Br J Dermatol. 2017. PMID: 27516004

7

Epidermal growth factor receptor inhibitor-associated rash prevented by oral tetracyclines.

van Doorn R, van Zuuren EJ. van Doorn R, et al. Among authors: van zuuren ej. Br J Dermatol. 2016 Dec;175(6):1135-1136. doi: 10.1111/bjd.15033. Br J Dermatol. 2016. PMID: 27996150 No abstract available.

8

Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group.

van Santen S, van Doorn R, Neelis KJ, Daniëls LA, Horváth B, Bruijn MS, Sanders CJG, van Rossum MM, de Haas ERM, Veraart JCJM, Bekkenk MW, Vermeer MH, Willemze R. van Santen S, et al. Among authors: van doorn r, van rossum mm. Br J Dermatol. 2017 Jul;177(1):223-228. doi: 10.1111/bjd.15355. Epub 2017 May 11. Br J Dermatol. 2017. PMID: 28132406

9

Incidence and outcome of Spitzoid tumour of unknown malignant potential (STUMP): an analysis of cases in the Netherlands from 1999 to 2014.

Ruijter CGH, Ouwerkerk W, Jaspars EH, van Doorn R, Luiten RM, Bekkenk MW, Tio DCKS. Ruijter CGH, et al. Among authors: van doorn r. Br J Dermatol. 2020 Dec;183(6):1121-1123. doi: 10.1111/bjd.19383. Epub 2020 Sep 1. Br J Dermatol. 2020. PMID: 32628276 No abstract available.

10

Mycosis fungoides: promoter hypermethylation predicts disease progression.

van Doorn R. van Doorn R. Br J Dermatol. 2014 Jun;170(6):1216. doi: 10.1111/bjd.12870. Br J Dermatol. 2014. PMID: 24947150 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page